Overview

Effect of Early Use of Caffeine Citrate in Preterm Neonates

Status:
Completed
Trial end date:
2019-06-10
Target enrollment:
0
Participant gender:
All
Summary
This work is designed to study the effect of the early use of caffeine citrate in preterm neonates who need respiratory support on morbidity and short term neonatal outcome.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ain Shams University
Treatments:
Caffeine
Caffeine citrate
Citric Acid
Sodium Citrate
Criteria
Inclusion Criteria:

1. Preterm neonates ≤ 33 weeks gestational age.

2. Preterm neonates who need respiratory support (either nasal canula, continuous
positive airway pressure (CPAP) or mechanical ventilation).

Exclusion Criteria:

1. Neonate>33 wks gestational age.

2. Neonates on room air.

3. Neonates with major congenital or cardiac anomalies